And This Year s Winner Is...The Microarray: Fodor Shares Views During Week of Awards | GenomeWeb

Last week was awards week for Affymetrix CEO Stephen Fodor. The first good news came from Japan: last Tuesday, the Takeda Foundation announced that it had jointly awarded this year’s prize for techno-entrepreneurial achievements in the category “individual/humanity well-being,” or life sciences, to Fodor, along with Pat Brown at Stanford, for the development and promotion of DNA microarrays.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.